Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.

This research investigates the sources of specific enzymes, matrix metalloproteinases (MMP -2 and -9), in horse joints that contribute to the breakdown of joint cartilage, a key component in osteoarthritis. The study suggests that managing these enzymes could be a potential therapy for preventing cartilage damage.

About Matrix Metalloproteinases (MMP-2 and MMP-9)

• Matrix Metalloproteinases (MMPs) are a family of enzymes that primarily break down extracellular matrix proteins, like those found in joint cartilage.
• MMP-2 and MMP-9 specifically, which are also known as gelatinase MMPs, were the focus in this research.
• Increased production or activity of these enzymes can lead to damage in the joint cartilage and instigate conditions like osteoarthritis, making them important targets for therapeutic intervention.

Key Findings of the Study

• Using tissue culture methods and gelatin zymography, the study identified various in-house (resident) and invasive (infiltrating inflammatory) cells that produce these enzymes in the joint.
• In short-term cultures, peripheral blood neutrophils produced MMP-9, and peripheral blood monocytes produced the same enzyme.
• Isolated articular chondrocytes, the cells responsible for maintaining cartilage health, produced both MMP-2 and MMP-9. However, when maintained as explant cultures, they produced MMP-2 alone.
• Synovial fibroblasts, another type of joint cell, also produced MMP-2 when cultured. When cultured as a complete synovial membrane, they made both MMP-2 and an active form of MMP-2.
• Interestingly, the blood polymorph neutrophils, upon being lysed (broken apart), released large quantities of MMP-9, suggesting that they store MMPs intracellularly. Other cells, upon lysis, released little enzyme.

Implications of These Findings

• The purification of equine MMP-2 from synovial fibroblast culture and MMP-9 from polymorph neutrophil culture further confirmed the presence and identity of these enzymes.
• The research provides valuable information about the cellular sources of these enzymes in joints.
• By showing that both invasive and resident joint cells can produce enzymes that break down cartilage matrix components, it suggests that therapeutic interventions could be aimed at controlling these enzymes to prevent cartilage destruction, thereby hindering the development of conditions like osteoarthritis.